AzTrials
AzTrials

Knowledge GapsNCT07865104

Addiction Psychoeducation for Canadian Muslims

A study testing Culturally sensitive addiction psychoeducation program and Secular in people with Knowledge Gaps and Attitudes, run by Centre for Addiction and Mental Health at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The Canadian Muslim Addiction Program (C-MAP) was designed as a pilot randomized controlled study using quantitative and qualitative methods to evaluate culturally and spiritually adapted addiction psychoeducation. Read more about this study

Who is it for?
Ages 16 years and olderHealthy volunteers can take part
What is being tested?
Culturally sensitive addiction psychoeducation program and Secular
Could I receive a placebo?
No, everyone receives an active treatment
How many people
187 participants
Where
1 siteCanada
Study dates
1 Dec 2023to 29 Aug 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Aged 16 years or older.
  • Self-identifies as belonging to one of the following three target populations:
  • Muslim individuals with lived experience of addiction, defined as self-reported lifetime substance use or problematic behaviours with difficulty stopping.
  • Muslim family members of individuals with addiction.
  • Muslim members of the general public who do not meet either of the preceding population definitions.

Who cannot join

  • Does not belong to any of the specified target populations.
  • Unable to communicate in English.

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • CAMH

    Toronto, Ontario, M6J1H4

Other trials in Canada

About this study

Official title: Canadian Muslim Addiction Program (C-MAP) Phase One: Evaluating a Novel Faith-Based Psychoeducation Program to Enhance Addictions Treatment

The Canadian Muslim Addiction Program (C-MAP) was designed as a pilot randomized controlled study using quantitative and qualitative methods to evaluate culturally and spiritually adapted addiction psychoeducation. Its aim is to reduce addiction-related stigma by improving knowledge, attitudes toward addiction, and professional help-seeking among Canadian Muslims.

The protocol specifies a target sample of 200-300 participants aged 16 years or older, drawn from three populations: Muslim individuals with lived experience of addiction, family members of individuals with addiction, and members of the Muslim general public. Participants are randomly assigned in a 1:1 ratio to either C-MAP psychoeducation incorporating Islamic perspectives or a control program covering similar addiction topics without spiritually adapted content. The study involves a single virtual session, with questionnaires administered before and after the intervention.

Self-report measures assess addiction-related knowledge, attitudes, stigma, and help-seeking, while open-ended questions explore participants' experiences and the perceived contribution of Islamic content. The study also examines whether baseline spirituality is associated with improvements in outcomes. Findings are intended to inform refinement of the program and provide feasibility information and effect-size estimates for a larger trial.

Being tested
Culturally sensitive addiction psychoeducation program, Secular
Medical subject headings
Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Culturally sensitive addiction psychoeducation programOther

    The Canadian Muslim Addiction Program (C-MAP) is a culturally and spiritually adapted addiction psychoeducation program for Muslim individuals with lived experience of addiction, family members of individuals with addiction, and members of the general public. It aims to reduce addiction-related stigma by increasing knowledge, improving attitudes toward addiction, and enhancing professional help-seeking.

    Participants receive the intervention during a single virtual study session through the secure Webex platform, with approximately 60-90 minutes devoted to the psychoeducation content. The content is organized into 17 short subtopics for each target population and addresses addictive substances and behaviors from an Islamic perspective.

    Topics include the causes and consequences of addiction, treatment options, harm reduction, and help-seeking. Evidence-based addiction information is integrated with Islamic perspectives, including the role of spiritual practices in treatment and

  • SecularOther

    The control program addresses similar addiction psychoeducation subtopics to C-MAP but does not include spiritually adapted content.

Study groups in NCT07865104
Study groupRoleWhat they receive
culturally and spiritually adapted addiction psychoeducation materialExperimentalNot described
Receives: Other: Culturally sensitive addiction psychoeducation program
Secular addiction psychoeducation materialActive comparatorNot described
Receives: Other: Secular

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quantitative changes: Change in addiction-related knowledge comparing culturally sensitive with secular psychoeducation.

    Stigma-related knowledge is assessed using the Mental Health Knowledge Schedule (MAKS). The knowledge score is calculated by summing the first six items, each scored from 1 to 5, with reverse coding applied as appropriate. The minimum possible score is 6 and the maximum possible score is 30. Higher scores indicate greater stigma-related mental health knowledge and represent a better outcome. An increase from baseline indicates improvement.

    Measured: baseline (pre-intervention) and immediately after the intervention

Secondary outcomes (1)
  1. Qualitative evaluation: Participants' perceptions of C-MAP and its perceived influence on addiction-related stigma.

    Qualitative evaluation of participants' perceptions, feelings, and experiences of the program, particularly its perceived influence on addiction-related stigma, bias, and attitudes toward addiction. Four open-ended questions explore the contribution of Islamic content and additional experiences not captured by the quantitative questionnaires. Responses are collected in writing through Research Electronic Data Capture software (REDCap) or through an optional individual interview and analyzed using qualitative content analysis to identify overarching themes and subthemes, illustrated by supporting participant quotations.

    Measured: Immediately after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Oct 2026
  2. Study start1 Dec 2023
  3. Primary completion29 Aug 2026
  4. Study completion29 Aug 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
187 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07865104
Sponsor's protocol ID
2023/016 version 9
Status last verified
Sep 2026
First submitted
25 Sep 2026
Last updated
8 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Elhai JD, Schweinle W, Anderson SM. Reliability and validity of the Attitudes Toward Seeking Professional Psychological Help Scale-Short Form. Psychiatry Res. 2008 Jun 30;159(3):320-9. doi: 10.1016/j.psychres.2007.04.020. Epub 2008 Apr 22.

    PubMed 18433879
  • Evans-Lacko S, Rose D, Little K, Flach C, Rhydderch D, Henderson C, Thornicroft G. Development and psychometric properties of the reported and intended behaviour scale (RIBS): a stigma-related behaviour measure. Epidemiol Psychiatr Sci. 2011 Sep;20(3):263-71. doi: 10.1017/s2045796011000308.

    PubMed 21922969
  • Al-Ghafri Q, Radcliffe P, Gilchrist G. Barriers and facilitators to accessing inpatient and community substance use treatment and harm reduction services for people who use drugs in the Muslim communities: A systematic narrative review of studies on the experiences of people who receive services and service providers. Drug Alcohol Depend. 2023 Mar 1;244:109790. doi: 10.1016/j.drugalcdep.2023.109790. Epub 2023 Jan 31.

    PubMed 36805826
  • Hassan AN, Agabani Z, Ahmed F, Shapiro B, Le Foll B. The Impact of religiosity/spirituality on slowing the progression of substance use: Based on the National Epidemiological Survey of Alcohol and Related Conditions (NESARC-III). Int J Soc Psychiatry. 2023 Sep;69(6):1399-1408. doi: 10.1177/00207640231162819. Epub 2023 Mar 23.

    PubMed 36951385
  • Hassan AN, Ragheb H, Malick A, Abdullah Z, Ahmad Y, Sunderji N, Islam F. Inspiring Muslim Minds: Evaluating a Spiritually Adapted Psycho-educational Program on Addiction to Overcome Stigma in Canadian Muslim Communities. Community Ment Health J. 2021 May;57(4):644-654. doi: 10.1007/s10597-020-00699-0. Epub 2020 Aug 25.

    PubMed 32844327

Questions about this trial

What is this clinical trial studying?

A study testing Culturally sensitive addiction psychoeducation program and Secular in people with Knowledge Gaps and Attitudes, run by Centre for Addiction and Mental Health at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quantitative changes: Change in addiction-related knowledge comparing culturally sensitive with secular psychoeducation. (time frame: baseline (pre-intervention) and immediately after the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07865104, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in